| 8:00 |
Registration |
|
Introductory Comments |
| 8:30 |
Dr. Gerald Levey
Dean, David Geffen School of Medicine; Vice Chancellor, UCLA
|
| |
Peter Whybrow
Director, UCLA Neuropsychiatric Institute |
Invited Presentations - Focus on Study Design and Analysis |
| 8:40 |
Pharmacogenomics: Is it More than Pharmacogenetics? |
Urs Meyer
University of Basel |
| 9:25 |
Family-based Approaches in Pharmacogenetics |
Richard Spielman
University of Pennsylvania |
| 10:10 |
Break |
|
| 10:30 |
Pharmacogenetics: Key to the Treatment of Common Diseases |
Kari Stefansson
deCode Genetics Iceland |
Presentations from PGRN Network Members |
| 11:15 |
Pharmacogenetics, cSNPs and Function |
Richard Weinshilboum
Mayo Clinic |
| 12:00 |
Poster Session and Lunch Break |
|
| 1:30 |
Pharmacogenetics of Lipoprotein Therapy |
Ronald Krauss
CHORI |
| 2:10 |
Pharmacogenetics of Asthma Treatment |
Scott Weiss
Harvard University |
| 2:50 |
Pharmacogenomics of Antidepressant Treatment Response in Mexican-Americans:
Phenotype to Genotype Studies |
Julio Licinio
UCLA |
| 3:30 |
Break |
|
| 3:50 |
Autonomic Pharmacodynamic Pharmacogenomics: How Genes Influence Human Autonomic
Nervous System Responses |
Daniel O'Connor
UC San Diego |
| 4:30 |
Pharmacogenetics of Antiarrhythmic Therapy |
Dan Roden
Vanderbilt University |
| 5:10 |
Closing Comments |
Richard Weinshilboum
Mayo Clinic |
| 6:30 |
Cocktail Hour (Cash Bar) |
|
| 7:00 |
Dinner |
|
